In vitro effects of myo-inositol on normokinetic human semen samples with nonlinear motility

Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10557-10563. doi: 10.26355/eurrev_201912_19697.

Abstract

Objective: As myo-inositol (MI) deficiency has been associated with impaired sperm quality, we aimed to assess its effects on sperm kinetics objectively, using a computer-aided sperm analysis (CASA) system.

Patients and methods: We evaluated 59 normokinetic semen samples with nonlinear progressive motility before and after incubation with a solution of MI. The samples were collected from healthy subjects aged 20-40 years who were attending our Laboratory of Seminology for fertility screening.

Results: We found a significant increase in linear progressive motility (28.2% ± 10.8 vs. 30.9% ± 11.0, T0 vs. T1 respectively; p <0.001) and a significant reduction in nonlinear progressive motility (21.0% ± 9.9 vs. 18.1% ± 10.2, T0 vs. T1 respectively; p <0.001) after incubation with MI. CASA analysis revealed a significant increase in curvilinear velocity (VCL) (65.0 ± 19.0 vs. 67.9 ± 20.4 µm/s, T0 vs. T1 respectively; p = 0.049). Overall, there was an increase in VCL in 42/59 samples (about 70%), mainly from non-smokers.

Conclusions: These results suggest that MI has a positive in vitro effect on semen samples, but confirmation is needed through further studies taking into account factors capable of modulating MI response, such as smoking and obesity.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Diagnosis, Computer-Assisted
  • Humans
  • Infertility, Male / diagnosis
  • Infertility, Male / drug therapy*
  • Infertility, Male / physiopathology
  • Inositol / pharmacology*
  • Inositol / therapeutic use
  • Male
  • Semen / drug effects
  • Semen / physiology*
  • Sperm Motility / drug effects*
  • Young Adult

Substances

  • Inositol